Journals / Journal of Basic and Clinical Health Sciences / 2019 / Volume: 3 Issue: 2

Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia

Zeynep Yüce(Dokuz Eylul University Faculty of Medicine, Department of Medical Biology, Izmir, Turkey)
Erdinç Yüksel(Dokuz Eylul University Hospital, Central Diagnostic Laboratory, Izmir, Turkey)
Melek Pehlivan(Dokuz Eylul University, Faculty of Medicine, Department of Hematology, Izmir, Turkey)
Ömür Gökmen Sevindik(Dokuz Eylul University, Faculty of Medicine, Department of Hematology, Izmir, Turkey)
İnci Alacacıoğlu(Dokuz Eylul University, Faculty of Medicine, Department of Hematology, Izmir, Turkey)
Oğuz Altungöz(Dokuz Eylul University Faculty of Medicine, Department of Medical Biology, Izmir, Turkey)
Pages
—
Publication Date
2019-06-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of tetrasomy was confirmed with C-MYC 8q24 , AML1/ETO ETO-8q21 and chromosome 8 centromeric probe cocktail.Conclusion: Recognition of the polysomy 8 syndrome will allow for the development of a standardized approach to these patients; as well as stimulating further research into the biology of the disorder that will allow for the development of better therapeutic strategies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Cytogenetic abnormalities have been proven to be among the most valuable prognostic indicators in leukemia, allowing the stratification of patients in risk groups.
📊
Key Findings & Data:We describe a patient diagnosed as AML-M5, with myeloid sarcoma and tetrasomy 8 as the sole chromosomal abnormality.
💡
Conclusion & Impact:The presence of tetrasomy was confirmed with C-MYC 8q24 , AML1/ETO ETO-8q21 and chromosome 8 centromeric probe cocktail.Conclusion: Recognition of the polysomy 8 syndrome will allow for the development of a standardized approach to these patients; as well as stimulating further research into the biology of the disorder that will allow for the development of better therapeutic strategies
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Tetrasomy 8 · Acute Myeloid Leukemia · AML-M5

Abstract

Purpose: Cytogenetic abnormalities have been proven to be among the most valuable prognostic indicators in leukemia, allowing the stratification of patients in risk groups. We describe a patient diagnosed as AML-M5, with myeloid sarcoma and tetrasomy 8 as the sole chromosomal abnormality. We confirm that the presence of polysomy 8 in myeloid lineage malignancies is associated with a distinct clinical entity comprising of myelomonocytic/monocytic lineage involvement, poor prognosis and high incidence of myeloid sarcoma. In aim to obtain a detailed description of this clinical entity, literature of polysomy 8 cases has been reviewed.Methods: Cytogenetic analysis was performed on bone marrow samples directly after aspiration and following 24 h short term culture. Fluorescence in situ hybridization FISH analyses were performed at complete remission stage on interphase nuclei from bone marrow.Results: Cytogenetic analyses revealed tetrasomy 8 as the sole karyotipic change in all metaphases. The presence of tetrasomy was confirmed with C-MYC 8q24 , AML1/ETO ETO-8q21 and chromosome 8 centromeric probe cocktail.Conclusion: Recognition of the polysomy 8 syndrome will allow for the development of a standardized approach to these patients; as well as stimulating further research into the biology of the disorder that will allow for the development of better therapeutic strategies

🔖

Cite This Article

Yüce, Z., Yüksel, E., Pehlivan, M., Sevindik, Ö. G., Alacacıoğlu, İ., Altungöz, O. (2019). Polysomy 8 Syndrome: A Distinct Clinical Entity Comprising of Myelomonocytic/Monocytic Lineage Involvement in Acute Leukemia. Journal of Basic and Clinical Health Sciences, Volume: 3 Issue: 2. https://doi.org/10.30621/jbachs.2019.505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:937–951. [CrossRef]
  2. Grimwade D, Hills RK, Moorman AV, et al.; National Cancer Research Institute Adult Leukaemia Working Group. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365. [CrossRef]
  3. Shaffer LG, Mc Gowan-Jordan J, Schmid M. ISCN 2013: an international system for human cytogenetic nomenclature. Basel: S. Karger; 2013.
  4. Kim J, Park TS, Song J, Lee KA, Lee SG, Cheong JW, Choi JR. Tetrasomy 8 in a patient with acute monoblastic leukemia. Korean J Lab Med 2008;28:262–266. [CrossRef]
  5. Aktas D, Tuncbilek E, Cetin M, Hicsonmez G. Tetrasomy 8 as a primary chromosomal abnormality in a child with acute megakaryoblastic leukemia: a case report and review of the literature. Cancer Genet Cytogenet 2001;126:166–168. [CrossRef]
  6. Sheila N, Sait J, Raza A, Sandberg. Tetrasomy of chromosome 8: An interesting and rare cytogenetic phenomenon in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987;27:269– 271. [CrossRef]
  7. Shao J, Zhang L, Semenza JC, Beach B, Smith MT. Tetrasomy 8 detected by interphase cytogenetics in a child with acute lymphocytic leukemia. Cancer Genet Cytogenet 1996;92:135–140. [CrossRef]
  8. de Oliveira FM, Brandão RA, Leite-Cueva SD, et al. Tetrasomy 8 in a patient with chronic lymphocytic leukemia. Cancer Genet Cytogenet 2010;198:166–169. [CrossRef]
  9. Beyer V, Mühlematter D, Parlier V, et al. Polysomy 8 defines a clinico- cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Cancer Genet Cytogenet 2005;160:97–119. [CrossRef]
  10. Shin SY, Koo SH, Kwon KC, et al. Chromosome 8 pentasomy with partial tandem duplication of 11q23 in a case of de novo acute myeloid leukemia. Cancer Genet Cytogenet 2009;194:44–47. [CrossRef]
  11. Kameoka J, Horiuchi T, Miyamura K, et al. Acute monoblastic leukemia with tetrasomy 8. Rinsho Ketsueki 2006;47:770–776.
  12. Makis W, Rakheja R, Lavoie J, Hickeson M. Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT. Nucl Med Mol Imaging 2012;46:119– 124. [CrossRef]
  13. Takahashi T, Tsukuda H, Kimura H, Yoshimoto M, Tsujisaki M. Extramedullary relapse of AML with t(9;11)(p22;q23) associated with clonal evolution from trisomy 8 into tetrasomy 8. Intern Med 2010;49:447–451. [CrossRef]
  14. Tsirigotis P, Papageorgiou S, Abatzis D, et al. Acute myelogenous leukemia with tetrasomy 8 is a disease with a poor prognosis. Cancer Genet Cytogenet 2005;161:78–81. [CrossRef]
  15. Jani Sait SN, Raza A, Sandberg AA. Tetrasomy of chromosome 8: an interesting and rare cytogenetic phenomenon in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1987;27:269– 271. [CrossRef]
  16. Solé F, de Pablos JM, Woessner S, et al Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis. Cancer Genet Cytogenet 1997;94:147–150. [CrossRef]
  17. Ferro MT, Vázquez-Mazariego Y, Ramiro S, et al. Trisomy/ tetrasomy of chromosome 8 and +i(8q) as the sole chromosome abnormality in three adult patients with myelomonocytic leukemia. Cancer Genet Cytogenet 2000;120:163–165. [CrossRef]
  18. Kameoka J, Funato T, Obara Y, et al. Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome. Cancer Genet Cytogenet 2001;124:159–164. [CrossRef]
  19. Yan J, Marceau D, Drouin R. Tetrasomy 8 is associated with a major cellular proliferative advantage and a poor prognosis. two cases of myeloid hematologic disorders and review of the literature. Cancer Genet Cytogenet 2001;125:14–20. [CrossRef]
  20. Abdelmoula NB, Landman-Parker J, Tourniaire B, et al. An aggressive Ewing sarcoma associated with a new variant translocation, t(4;11;22) (q25;q24;q12), hyperdiploid karyotype, and tetrasomy 8. Cancer Genet Cytogenet 2005;163:186–188. [CrossRef]
  21. Trakhtenbrot L, Neumann Y, Mandel M, et al. In vitro proliferative advantage of bone marrow cells with tetrasomy 8 in Ewing sarcoma. Cancer Genet Cytogenet 1996;90:176–178. [CrossRef]
  22. Lessard M, Herry A, Berthou C, et al. Chromosome 8 tetrasomies and pentasomies--a clonal abnormality closely associated with acute monocytic leukaemia. Leuk Lymphoma 1997;27:127–135. [CrossRef]
  23. Zhang XX, Robinson LJ, Stenzel TT, Qumsiyeh MB. Translocation (15;17)(q22;q21) as a secondary chromosomal abnormality in a case of acute monoblastic leukemia with tetrasomy 8. Cancer Genet Cytogenet 1999;113:9–13. [CrossRef]
  24. Alonso-Dominguez JM, Calbacho M, Talavera M, et al. Cytogenetics findings in a histiocytic sarcoma case. Case Rep Hematol 2012;2012:428279. [CrossRef]
  25. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2014. Mitelman F, Johansson B, Mertens F, editors. [CrossRef]